Rtw Investments as of Dec. 31, 2021
Portfolio Holdings for Rtw Investments
Rtw Investments holds 124 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr S&p 500 Etf Tr Tr Unit (SPY) | 6.2 | $423M | 890k | 474.96 | |
Rocket Pharmaceuticals (RCKT) | 5.0 | $345M | 16M | 21.83 | |
Alnylam Pharmaceuticals (ALNY) | 4.9 | $335M | 2.0M | 169.58 | |
Thermo Fisher Scientific (TMO) | 4.2 | $291M | 436k | 667.24 | |
Masimo Corporation (MASI) | 3.6 | $249M | 850k | 292.78 | |
Mirati Therapeutics | 3.3 | $229M | 1.6M | 146.69 | |
Ptc Therapeutics I (PTCT) | 3.1 | $211M | 5.3M | 39.83 | |
Illumina (ILMN) | 2.7 | $187M | 490k | 380.44 | |
Penumbra (PEN) | 2.6 | $178M | 621k | 287.32 | |
Vericel (VCEL) | 2.6 | $178M | 4.5M | 39.30 | |
Tandem Diabetes Care Com New (TNDM) | 2.6 | $175M | 1.2M | 150.52 | |
Natera (NTRA) | 2.5 | $174M | 1.9M | 93.39 | |
Establishment Labs Holdings Ord (ESTA) | 2.3 | $157M | 2.3M | 67.59 | |
Celldex Therapeutics Com New (CLDX) | 2.2 | $152M | 3.9M | 38.64 | |
Prometheus Biosciences | 1.9 | $129M | 3.3M | 39.54 | |
Globus Med Cl A (GMED) | 1.8 | $121M | 1.7M | 72.20 | |
Cytokinetics Com New (CYTK) | 1.7 | $117M | 2.6M | 45.58 | |
Ultragenyx Pharmaceutical (RARE) | 1.7 | $116M | 1.4M | 84.09 | |
Avidity Biosciences Ord (RNA) | 1.7 | $114M | 4.8M | 23.77 | |
Iveric Bio | 1.6 | $112M | 6.7M | 16.72 | |
Argenx Se Sponsored Adr (ARGX) | 1.6 | $111M | 317k | 350.19 | |
Iteos Therapeutics (ITOS) | 1.6 | $110M | 2.4M | 46.56 | |
10x Genomics Cl A Com (TXG) | 1.6 | $109M | 735k | 148.96 | |
Axonics Modulation Technolog (AXNX) | 1.6 | $109M | 1.9M | 56.00 | |
Apellis Pharmaceuticals (APLS) | 1.4 | $94M | 2.0M | 47.28 | |
Protagonist Therapeutics (PTGX) | 1.3 | $89M | 2.6M | 34.20 | |
Stoke Therapeutics (STOK) | 1.3 | $87M | 3.6M | 23.99 | |
Guardant Health (GH) | 1.2 | $81M | 813k | 100.02 | |
C4 Therapeutics Com Stk (CCCC) | 1.2 | $80M | 2.5M | 32.20 | |
Pmv Pharmaceuticals (PMVP) | 1.0 | $69M | 3.0M | 23.10 | |
Fulcrum Therapeutics (FULC) | 1.0 | $68M | 3.9M | 17.69 | |
Macrogenics (MGNX) | 0.9 | $64M | 4.0M | 16.05 | |
Axsome Therapeutics (AXSM) | 0.9 | $61M | 1.6M | 37.78 | |
Regenxbio Inc equity us cm (RGNX) | 0.9 | $60M | 1.8M | 32.70 | |
Ideaya Biosciences (IDYA) | 0.9 | $60M | 2.5M | 23.64 | |
Cutera (CUTR) | 0.8 | $58M | 1.4M | 41.32 | |
Proqr Thrapeutics N V Shs Euro (PRQR) | 0.8 | $56M | 7.0M | 8.01 | |
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.8 | $53M | 869k | 60.87 | |
Adicet Bio (ACET) | 0.8 | $53M | 3.0M | 17.49 | |
Sarepta Therapeutics (SRPT) | 0.8 | $52M | 582k | 90.05 | |
Gh Research Ordinary Shares (GHRS) | 0.7 | $51M | 2.2M | 23.33 | |
Science 37 Holdings | 0.7 | $50M | 4.0M | 12.47 | |
Dermtech Ord ord (DMTKQ) | 0.7 | $49M | 3.1M | 15.80 | |
Relmada Therapeutics (RLMD) | 0.7 | $49M | 2.2M | 22.53 | |
Bellus Health Com New | 0.7 | $48M | 6.0M | 8.05 | |
Tenaya Therapeutics (TNYA) | 0.7 | $47M | 2.5M | 18.95 | |
Avadel Pharmaceuticals Sponsored Adr | 0.7 | $46M | 5.7M | 8.08 | |
Tarsus Pharmaceuticals (TARS) | 0.7 | $45M | 2.0M | 22.50 | |
Apyx Medical Corporation (APYX) | 0.6 | $44M | 3.4M | 12.82 | |
Immunocore Hldgs Ads (IMCR) | 0.6 | $43M | 1.2M | 34.24 | |
Outset Med (OM) | 0.6 | $41M | 895k | 46.09 | |
Oyster Point Pharma | 0.5 | $38M | 2.1M | 18.26 | |
Essa Pharma Com New (EPIX) | 0.5 | $37M | 2.6M | 14.20 | |
Pulmonx Corp (LUNG) | 0.5 | $37M | 1.2M | 32.07 | |
Ventyx Biosciences (VTYX) | 0.5 | $31M | 1.6M | 19.86 | |
Quanterix Ord (QTRX) | 0.4 | $29M | 687k | 42.40 | |
Milestone Pharmaceuticals (MIST) | 0.4 | $28M | 4.3M | 6.55 | |
Cytomx Therapeutics (CTMX) | 0.4 | $26M | 6.0M | 4.33 | |
Castle Biosciences (CSTL) | 0.4 | $26M | 599k | 42.87 | |
Nanostring Technologies (NSTGQ) | 0.4 | $26M | 604k | 42.23 | |
Athira Pharma (ATHA) | 0.4 | $25M | 1.9M | 13.03 | |
Monte Rosa Therapeutics (GLUE) | 0.4 | $25M | 1.2M | 20.42 | |
Jounce Therapeutics | 0.3 | $24M | 2.9M | 8.35 | |
Pyxis Oncology Common Stock (PYXS) | 0.3 | $23M | 2.1M | 10.97 | |
Arrowhead Pharmaceuticals (ARWR) | 0.3 | $23M | 347k | 66.30 | |
Cerevel Therapeutics Hldng I (CERE) | 0.3 | $22M | 667k | 32.42 | |
Johnson & Johnson (JNJ) | 0.3 | $21M | 125k | 171.07 | |
Sight Sciences (SGHT) | 0.3 | $21M | 1.2M | 17.57 | |
Landos Biopharma | 0.3 | $21M | 4.3M | 4.80 | |
Renovacor | 0.3 | $20M | 2.6M | 7.70 | |
Agenus Com New | 0.3 | $19M | 5.9M | 3.22 | |
Olink Hldg Ab Sponsored Ads (OLK) | 0.3 | $19M | 1.0M | 18.20 | |
Aadi Bioscience (AADI) | 0.3 | $19M | 765k | 24.15 | |
Tela Bio (TELA) | 0.3 | $18M | 1.4M | 12.80 | |
Immunic (IMUX) | 0.2 | $16M | 1.7M | 9.57 | |
Adverum Biotechnologies | 0.2 | $13M | 7.6M | 1.76 | |
Brainsway Sponsored Ads (BWAY) | 0.2 | $12M | 1.6M | 7.70 | |
La Jolla Pharmaceutical Com Par $.0001 2 | 0.2 | $11M | 2.3M | 4.65 | |
Neogenomics Com New (NEO) | 0.2 | $11M | 311k | 34.12 | |
Clearside Biomedical (CLSD) | 0.2 | $11M | 3.8M | 2.75 | |
OraSure Technologies (OSUR) | 0.1 | $10M | 1.2M | 8.69 | |
Arbutus Biopharma (ABUS) | 0.1 | $9.7M | 2.5M | 3.89 | |
Exagen (XGN) | 0.1 | $9.6M | 821k | 11.63 | |
Genetron Hldgs Ads | 0.1 | $8.7M | 1.4M | 6.10 | |
Urogen Pharma (URGN) | 0.1 | $8.2M | 858k | 9.51 | |
Roivant Sciences SHS (ROIV) | 0.1 | $8.1M | 803k | 10.08 | |
Nyxoah S A SHS (NYXH) | 0.1 | $7.9M | 345k | 23.00 | |
Vincerx Pharma Com New (VINC) | 0.1 | $7.6M | 741k | 10.19 | |
Merus N V (MRUS) | 0.1 | $6.2M | 196k | 31.80 | |
Research Alliance Corp Ii Com Cl A | 0.1 | $6.2M | 637k | 9.72 | |
Bcls Acquisition Corp Com Cl A | 0.1 | $6.0M | 613k | 9.80 | |
Nautilus Biotechnology (NAUT) | 0.1 | $5.7M | 1.1M | 5.18 | |
Summit Healthcre Acquistn Unit 06/03/2026 | 0.1 | $5.0M | 500k | 9.95 | |
Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.1 | $5.0M | 500k | 9.92 | |
Procept Biorobotics Corp (PRCT) | 0.1 | $4.9M | 194k | 25.01 | |
Arya Sciences Acquisitn Corp Class A Ord Shs | 0.1 | $4.9M | 500k | 9.70 | |
Immatics SHS (IMTX) | 0.1 | $4.7M | 350k | 13.44 | |
Biomea Fusion (BMEA) | 0.1 | $4.4M | 594k | 7.45 | |
Sophia Genetics Sa Ordinary Shares (SOPH) | 0.1 | $4.2M | 300k | 14.10 | |
5 01 Acquisition Corp Com Cl A | 0.1 | $3.9M | 392k | 9.85 | |
Aslan Pharmaceuticals Ads | 0.1 | $3.6M | 3.3M | 1.12 | |
Isoplexis Corp | 0.0 | $3.4M | 365k | 9.19 | |
Medicus Sciences Acquisition Cl A Shs | 0.0 | $2.9M | 300k | 9.69 | |
Maxcyte (MXCT) | 0.0 | $2.8M | 275k | 10.19 | |
Point Biopharma Global | 0.0 | $2.7M | 490k | 5.60 | |
Connect Biopharma Hldgs Ads (CNTB) | 0.0 | $2.3M | 450k | 5.15 | |
Apollo Endosurgery | 0.0 | $2.2M | 258k | 8.43 | |
Codex Dna | 0.0 | $2.2M | 200k | 10.80 | |
Tango Therapeutics (TNGX) | 0.0 | $2.0M | 181k | 10.94 | |
Mink Therapeutics (INKT) | 0.0 | $1.9M | 417k | 4.46 | |
MiMedx (MDXG) | 0.0 | $1.8M | 296k | 6.04 | |
Sema4 Holdings Corp Com Cl A | 0.0 | $1.8M | 400k | 4.46 | |
Rxsight (RXST) | 0.0 | $1.7M | 150k | 11.25 | |
Akoya Biosciences (AKYA) | 0.0 | $1.5M | 100k | 15.31 | |
Miromatrix Med | 0.0 | $1.3M | 280k | 4.69 | |
Avita Therapeutics (RCEL) | 0.0 | $1.3M | 107k | 11.98 | |
Singular Genomics Systems In | 0.0 | $1.2M | 100k | 11.56 | |
908 Devices (MASS) | 0.0 | $1.0M | 40k | 25.88 | |
Minerva Surgical | 0.0 | $853k | 166k | 5.14 | |
Bolt Biotherapeutics (BOLT) | 0.0 | $619k | 126k | 4.90 | |
Zymergen | 0.0 | $468k | 70k | 6.69 | |
Renovacor *w Exp 99/99/999 | 0.0 | $200k | 350k | 0.57 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.0 | $61k | 12k | 4.99 | |
Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $24k | 33k | 0.72 |